Medicare Part D Coverage and Costs for Glucagon-Like Peptide-1 Receptor Agonists
This cross-sectional study examines Medicare Part D coverage and out-of-pocket costs for glucagon-like peptide-1 receptor agonists following implementation of the Inflation Reduction Act.
Authors
- Judith Long (ORCID: https://orcid.org/0000-0002-6311-2101)
- Matthew J. Klebanoff (ORCID: https://orcid.org/0000-0002-5081-063X)
- Jalpa A. Doshi (ORCID: https://orcid.org/0000-0002-3263-4337)
- Pengxiang Li (ORCID: https://orcid.org/0000-0002-0795-6684)
Institutions
- Philadelphia VA Medical Center (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- JAMA
- Published
- 2025-09-24
- DOI
- https://doi.org/10.1001/jama.2025.15841
- Citations
- 2
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 3.03